The Week Ahead In Biotech: Smid-Cap Earnings News Flow Picks Up Pace

Biotech stocks started last week on a strong note but the upward momentum slowed through the week. The week saw a slew of earnings from big pharma names, including Merck & Co., Inc. MRK and Pfizer Inc. PFE. Merck disappointed by lowering its outlook, although sell-side stayed positive on the prospects.

Presentations at the American Association of Cancer Research Virtual Conference created some volatility. Verastem Inc VSTM became a casualty of "not-so-impressive" clinical data on its Phase 1 asset VS-6766 that targets KRAS mutant advanced solid tumors. The stock shed about 57% to a low of $1.77  before recovering some lost ground.

Here are the key catalysts for the unfolding week.

Conferences

SunTrust Robinson Humphrey 6th Annual Life Sciences Summit (Virtual Conference): May 5–6
Maxim Group M-Vest Infectious Disease Virtual Conference: May 5

Related Link: A Deep Dive On Coronavirus Vaccine Plays Moderna, Inovio

Clinical Readouts

Adverum Biotechnologies Inc ADVM is scheduled to present new data from the OPTIC Phase1 clinical trial of ADVM-022 intravitreal gene therapy in wet age-related macular degeneration. The call discussing the results is scheduled for Monday afternoon.

Auris Medical Holding Ltd EARS is due to release top-line data from the completed Phase 1b AM-201 trial in early May. AM-201 is being evaluated in antipsychotic-induced weight gain.

Early Q2 Schedule

Ovid Therapeutics Inc OVID: Phase 2 top-line data for OV101 in Fragile X syndrome

Iterum Therapeutics PLC ITRM: Phase 3 data for Sulopenem in uncomplicated and complicated urinary tract infections

Enanta Pharmaceuticals Inc ENTA: data from our INTREPID study of EDP-305 in patients with primary biliary cholangitis

Earnings

Monday

• Marinus Pharmaceuticals Inc MRNS (before the market open)
• Minerva Neurosciences Inc NERV (before the market open)
• Epizyme Inc EPZM (before the market open)
• SI-Bone Inc SIBN (after the market close)
• Corcept Therapeutics Incorporated CORT (after the market close)
• Chembio Diagnostics Inc CEMI (after the market close)
• GenMark Diagnostics, Inc GNMK (after the market close)
• Kura Oncology Inc KURA (after the market close)
• Varian Medical Systems, Inc. VAR (after the market close)
• Fulgent Genetics Inc FLGT (after the market close)

See Also: Inovio Analysts Project About 24% Upside Potential Amid Optimism On Coronavirus DNA Vaccine

Tuesday

• Oxford Immunotec Global PLC OXFD (before the market open)
• Karyopharm Therapeutics Inc KPTI (before the market open)
• Haemonetics Corporation HAE (before the market open)
• Antares Pharma Inc ATRS (before the market open)
• Harvard Bioscience, Inc. HBIO (before the market open)
• Vericel Corp VCEL (before the market open)
• Regeneron Pharmaceuticals Inc REGN (before the market open)
• Neuronetics Inc STIM (before the market open)
• Mallinckrodt PLC MNK (before the market open)
• Akebia Therapeutics Inc AKBA (before the market open)
• Agile Therapeutics Inc AGRX (after the market close)
• Aquestive Therapeutics Inc AQST (after the market close)
• Akcea Therapeutics Inc AKCA (after the market close)
• Acorda Therapeutics Inc ACOR (after the market close)
• Axonics Modulation Technologies Inc AXNX (after the market close)
• Synthetic Biologics Inc SYN (after the market close)
• T2 Biosystems Inc TTOO (after the market close)
• Iovance Biotherapeutics Inc IOVA (after the market close)
• MacroGenics Inc MGNX (after the market close)
• Zogenix, Inc. ZGNX (after the market close)
• Jazz Pharmaceuticals PLC JAZZ (after the market close)
• Exelixis, Inc. EXEL (after the market close)
• Myriad Genetics, Inc. MYGN (after the market close)
• Inspire Medical Systems Inc INSP (after the market close)
• Rigel Pharmaceuticals, Inc. RIGL (after the market close)
• Supernus Pharmaceuticals Inc SUPN (after the market close)
• Nevro Corp NVRO (after the market close)
• Clovis Oncology Inc CLVS (after the market close)
• InVitae Corp NVTA (after the market close)
• Cytosorbents Corp CTSO (after the market close)
• Cardiovascular Systems Inc CSII (after the market close)
• Cerus Corporation CERS (after the market close)
• Deciphera Pharmaceuticals Inc DCPH (after the market close)
• Incyte Corporation INCY (after the market close)
• Orthopediatrics Corp KIDS (after the market close)

Wednesday

• Eyepoint Pharmaceuticals Inc EYPT (before the market open)
• Horizon Therapeutics PLC HZNP (before the market open)
• Constellation Pharmaceuticals Inc CNST (before the market open)
• Alnylam Pharmaceuticals, Inc. ALNY (before the market open)
• IVERIC bio Inc ISEE (before the market open)
• Blueprint Medicines Corp BPMC (before the market open)
• BioCryst Pharmaceuticals, Inc. BCRX (before the market open)
• Strongbridge Biopharma plc SBBP (before the market open)
• Evofem Biosciences, Inc. EVFM (before the market open)
• Neurocrine Biosciences, Inc. NBIX (before the market open)
• Jounce Therapeutics Inc JNCE (before the market open)
• PPD Inc PPD (before the market open)
• Zoetis Inc ZTS (before the market open)
• Ionis Pharmaceuticals Inc IONS (before the market open)
• TherapeuticsMD Inc TXMD (before the market open)
• Avanos Medical Inc AVNS (before the market open)
• Aerie Pharmaceuticals Inc AERI (after the close)
• Allogene Therapeutics Inc ALLO (after the close)
• ADMA Biologics Inc ADMA (after the close)
• Alexion Pharmaceuticals, Inc. ALXN (after the close)
• AxoGen, Inc Common Stock AXGN (after the close)
• Global Blood Therapeutics Inc GBT (after the close)
• Pacific Biosciences of California PACB (after the close)
• Theravance Biopharma Inc TBPH (after the close)
• BioTelemetry Inc BEAT (after the close)
• Bio-Rad Laboratories, Inc. BIO (after the close)
• Veracyte Inc VCYT (after the close)
• Ligand Pharmaceuticals Inc. LGND (after the close)
• Precigen Inc PGEN (after the close)
• Ironwood Pharmaceuticals, Inc. IRWD (after the close)
• OraSure Technologies, Inc. OSUR (after the close)
• NuVasive, Inc. NUVA (after the close)
• Sarepta Therapeutics Inc SRPT (after the close)
• Natera Inc NTRA (after the close)
• Vanda Pharmaceuticals Inc. VNDA (after the close)
• Qiagen NV QGEN (after the close)
• Enanta Pharmaceuticals Inc ENTA (after the close)
• Esperion Therapeutics Inc ESPR (after the close)
• G1 Therapeutics Inc GTHX (after the close)
• Quidel Corporation QDEL (after the close)
• Cytokinetics, Inc. CYTK (after the close)
• MannKind Corporation MNKD (after the close)

Thursday

• Integra Lifesciences Holdings Corp IART (before the market open)
• Intra-Cellular Therapies Inc ITCI (before the market open)
• Endo International PLC ENDP (before the market open)
• Xeris Pharmaceuticals Inc XERS (before the market open)
• Moderna Inc MRNA (before the market open)
• Syros Pharmaceuticals Inc SYRS (before the market open)
• Elanco Animal Health Inc ELAN (before the market open)
• Athenex Inc ATNX (before the market open)
• Aldeyra Therapeutics Inc ALDX (before the market open)
• Albireo Pharma Inc ALBO (before the market open)
• ANI Pharmaceuticals Inc ANIP (before the market open)
• Agenus Inc AGEN (before the market open)
• Amicus Therapeutics, Inc. FOLD (before the market open)
• Brainstorm Cell Therapeutics Inc BCLI (before the market open)
• Bristol-Myers Squibb Co BMY (before the market open)
• Progenics Pharmaceuticals, Inc. PGNX (before the market open)
• X4 Pharmaceuticals Inc XFOR (before the market open)
• Miragen Therapeutics Inc MGEN (before the market open)
• Kala Pharmaceuticals Inc KALA (before the market open)
• Seres Therapeutics Inc MCRB (before the market open)
• Intellia Therapeutics Inc NTLA (before the market open)
• Momenta Pharmaceuticals, Inc. MNTA (before the market open)
• Editas Medicine Inc EDIT (before the market open)
• Pacira Biosciences Inc PCRX (before the market open)
• Syndax Pharmaceuticals Inc SNDX (after the close)
• Tricida Inc TCDA (after the close)
• Helius Medical Technologies Inc HSDT (after the close)
• Twist Bioscience Corp TWST (after the close)
• Athersys Inc ATHX (after the close)
• Accelerate Diagnostics Inc AXDX (after the close)
• Adamas Pharmaceuticals Inc ADMS (after the close)
• Arena Pharmaceuticals, Inc. ARNA (after the close)
• Anika Therapeutics Inc ANIK (after the close)
• Arrowhead Pharmaceuticals Inc ARWR (after the close)
• ACADIA Pharmaceuticals Inc. ACAD (after the close)
• Calithera Biosciences Inc CALA (after the close)
• BioDelivery Sciences International, Inc. BDSI (after the close)
• Puma Biotechnology Inc PBYI (after the close)
• Coherus Biosciences Inc CHRS (after the close)
• Kindred Biosciences Inc KIN (after the close)
• PDL BioPharma Inc PDLI (after the close)
• Rockwell Medical Inc RMTI (after the close)
• Penumbra Inc PEN (after the close)
• Pfenex Inc PFNX (after the close)
• ZIOPHARM Oncology Inc. ZIOP (after the close)
• NovaBay Pharmaceuticals, Inc. NBY (after the close)
• ICU Medical Inc ICUI (after the close)
• Nektar Therapeutics NKTR (after the close)
• Savara Inc SVRA (after the close)
• Sunesis Pharmaceuticals, Inc. SNSS (after the close)
• OptiNose Inc OPTN (after the close)
• Eloxx Pharmaceuticals Inc ELOX (after the close)
• Five Prime Therapeutics Inc FPRX (after the close)
• Flexion Therapeutics Inc FLXN (after the close)
• FibroGen Inc FGEN (after the close)
• Globus Medical Inc GMED (after the close)
• Guardant Health Inc GH (after the close)
• OpGen Inc OPGN (after the close)
• Lineage Cell Therapeutics Inc LCTX (after the close)
• Dynavax Technologies Corporation DVAX (after the close)
• Chiasma Inc CHMA (after the close)
• Collegium Pharmaceutical Inc COLL (after the close)
• Dicerna Pharmaceuticals Inc DRNA (after the close)
• Caladrius Biosciences Inc CLBS (after the close)
• Glaukos Corp GKOS (after the close)
• Celcuity Inc CELC (after the close)
• Codexis, Inc. CDXS (after the close)
• CytomX Therapeutics Inc CTMX (after the close)
• Insulet Corporation PODD (after the close)

Friday

• Meridian Bioscience, Inc. VIVO (before the market open)
• Mersana Therapeutics Inc MRSN (before the market open)
• Ocular Therapeutix Inc OCUL (before the market open)